PL3033104T3 - Sposoby zwiększania natężonej objętości wydechowej u astmatyków za pomocą benralizumabu - Google Patents

Sposoby zwiększania natężonej objętości wydechowej u astmatyków za pomocą benralizumabu

Info

Publication number: PL3033104T3
Authority: PL; Poland
Prior art keywords: benralizumab; asthmatics; methods; expiratory volume; forced expiratory
Prior art date: 2013-08-12

Application number

PL14836725T

Other languages

English (en)

Inventor

Christine Ward

Lorin Roskos

Bing Wang

Donald Raible

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-08-12

Filing date

2014-08-07

Publication date

2019-09-30

2014-08-07 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2019-09-30 Publication of PL3033104T3 publication Critical patent/PL3033104T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
Mycology (AREA)
Biomedical Technology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Endocrinology (AREA)

PL14836725T 2013-08-12 2014-08-07 Sposoby zwiększania natężonej objętości wydechowej u astmatyków za pomocą benralizumabu PL3033104T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201361864948P	2013-08-12	2013-08-12
PCT/US2014/050119 WO2015023507A2 (en)	2013-08-12	2014-08-07	Methods for increasing forced expiratory volume in asthmatics using benralizumab
EP14836725.3A EP3033104B1 (en)	2013-08-12	2014-08-07	Methods for increasing forced expiratory volume in asthmatics using benralizumab

Publications (1)

Publication Number	Publication Date
PL3033104T3 true PL3033104T3 (pl)	2019-09-30

Family

ID=52448838

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL14836725T PL3033104T3 (pl)	2013-08-12	2014-08-07	Sposoby zwiększania natężonej objętości wydechowej u astmatyków za pomocą benralizumabu
PL19158446T PL3520811T3 (pl)	2013-08-12	2014-08-07	Sposoby zwiększania natężonej objętości wydechowej u astmatyków za pomocą benralizumabu

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL19158446T PL3520811T3 (pl)	2013-08-12	2014-08-07	Sposoby zwiększania natężonej objętości wydechowej u astmatyków za pomocą benralizumabu

Country Status (26)

Country	Link
US (1)	US9441046B2 (pl)
EP (5)	EP4579236A3 (pl)
JP (4)	JP6746496B2 (pl)
KR (1)	KR102337599B1 (pl)
CN (2)	CN111588849A (pl)
AU (2)	AU2014306959B2 (pl)
BR (1)	BR112016002317A8 (pl)
CA (1)	CA2917603C (pl)
CY (2)	CY1122033T1 (pl)
DK (2)	DK3520811T3 (pl)
ES (2)	ES2866426T3 (pl)
HK (1)	HK1222559A1 (pl)
HR (2)	HRP20190920T1 (pl)
HU (2)	HUE053627T2 (pl)
LT (2)	LT3520811T (pl)
ME (1)	ME03403B (pl)
MX (2)	MX381102B (pl)
PL (2)	PL3033104T3 (pl)
PT (2)	PT3033104T (pl)
RS (2)	RS58711B1 (pl)
RU (1)	RU2703568C2 (pl)
SG (1)	SG11201600483QA (pl)
SI (2)	SI3520811T1 (pl)
SM (2)	SMT201900311T1 (pl)
TR (1)	TR201907907T4 (pl)
WO (1)	WO2015023507A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE057065T2 (hu) *	2013-08-12	2022-04-28	Astrazeneca Ab	Eljárások asztma tüneteinek javítására benralizumab alkalmazásával
EP3033101B1 (en) *	2013-08-12	2018-12-19	AstraZeneca AB	Methods for reducing exacerbation rates of asthma using benralizumab
CN113230399A (zh) *	2013-10-15	2021-08-10	阿斯利康(瑞典)有限公司	用于使用贝那利珠单抗治疗慢性阻塞性肺疾病的方法
RS62419B1 (sr) *	2013-10-24	2021-10-29	Astrazeneca Ab	Stabilne vodene formulacije antitela
TW202110479A (zh) *	2019-05-16	2021-03-16	瑞典商阿斯特捷利康公司	使用貝那利珠單抗治療增強型患者群體慢性阻塞性肺病之方法
TW202126688A (zh) *	2019-09-27	2021-07-16	瑞典商阿斯特捷利康公司	使用貝那利珠單抗治療遲發性氣喘之方法
TW202214692A (zh) *	2020-06-05	2022-04-16	瑞典商阿斯特捷利康公司	治療患有鼻瘜肉的患者的重度氣喘之方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE283926T1 (de)	1995-09-11	2004-12-15	Kyowa Hakko Kogyo Kk	Antikörper gegen die alpha-kette von humanem interleukin 5 rezeptor
US6746839B1 (en) *	1998-01-12	2004-06-08	Interleukin Genetics, Inc.	Diagnostics and therapeutics for an obstructive airway disease
EP2278003B2 (en)	1999-04-09	2020-08-05	Kyowa Kirin Co., Ltd.	Method for controlling the activity of immunologically functional molecule
EP1266663A4 (en)	2000-02-15	2003-07-23	Kyowa Hakko Kogyo Kk	INDUCER OF EOSINOPHILIC SPECIFIC APOPTOSIS
US6946292B2 (en)	2000-10-06	2005-09-20	Kyowa Hakko Kogyo Co., Ltd.	Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US7662925B2 (en)	2002-03-01	2010-02-16	Xencor, Inc.	Optimized Fc variants and methods for their generation
WO2005035583A1 (ja)	2003-10-08	2005-04-21	Kyowa Hakko Kogyo Co., Ltd.	Ｉｌ－５受容体に特異的に結合する抗体組成物
US20060014680A1 (en)	2004-07-13	2006-01-19	Caiding Xu	Peptides and compounds that bind to the IL-5 receptor
WO2007041635A2 (en)	2005-10-03	2007-04-12	Xencor, Inc.	Fc variants with optimized fc receptor binding properties
CA2685222C (en) *	2007-05-14	2017-12-19	Medimmune, Llc	Methods of reducing eosinophil levels
RU2383345C1 (ru) *	2008-08-07	2010-03-10	Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА")	Способ лечения больных бронхиальной астмой
AU2011343570B2 (en) *	2010-12-16	2016-11-03	Genentech, Inc.	Diagnosis and treatments relating to TH2 inhibition
CN102544908B (zh)	2010-12-17	2016-01-06	富士康(昆山)电脑接插件有限公司	电连接器组件及插头连接器
US8961965B2 (en) *	2011-05-18	2015-02-24	Medimmune, Llc	Methods of diagnosing and treating pulmonary diseases or disorders
CA2853858A1 (en)	2011-11-01	2013-05-10	Medimmune, Llc	Methods for reducing the frequency and severity of acute exacerbations of asthma
EP3033101B1 (en) *	2013-08-12	2018-12-19	AstraZeneca AB	Methods for reducing exacerbation rates of asthma using benralizumab
HUE057065T2 (hu) *	2013-08-12	2022-04-28	Astrazeneca Ab	Eljárások asztma tüneteinek javítására benralizumab alkalmazásával

2014
- 2014-08-07 PT PT14836725T patent/PT3033104T/pt unknown
- 2014-08-07 ES ES19158446T patent/ES2866426T3/es active Active
- 2014-08-07 PT PT191584465T patent/PT3520811T/pt unknown
- 2014-08-07 SG SG11201600483QA patent/SG11201600483QA/en unknown
- 2014-08-07 RS RS20190556A patent/RS58711B1/sr unknown
- 2014-08-07 HK HK16110776.1A patent/HK1222559A1/zh unknown
- 2014-08-07 DK DK19158446.5T patent/DK3520811T3/da active
- 2014-08-07 EP EP25150773.7A patent/EP4579236A3/en active Pending
- 2014-08-07 RU RU2016108809A patent/RU2703568C2/ru active
- 2014-08-07 SI SI201431795T patent/SI3520811T1/sl unknown
- 2014-08-07 SI SI201431191T patent/SI3033104T1/sl unknown
- 2014-08-07 HU HUE19158446A patent/HUE053627T2/hu unknown
- 2014-08-07 MX MX2016001384A patent/MX381102B/es unknown
- 2014-08-07 JP JP2016534615A patent/JP6746496B2/ja active Active
- 2014-08-07 CN CN202010450690.6A patent/CN111588849A/zh active Pending
- 2014-08-07 DK DK14836725.3T patent/DK3033104T3/da active
- 2014-08-07 SM SM20190311T patent/SMT201900311T1/it unknown
- 2014-08-07 HU HUE14836725A patent/HUE043497T2/hu unknown
- 2014-08-07 TR TR2019/07907T patent/TR201907907T4/tr unknown
- 2014-08-07 LT LTEP19158446.5T patent/LT3520811T/lt unknown
- 2014-08-07 AU AU2014306959A patent/AU2014306959B2/en active Active
- 2014-08-07 CN CN201480045047.8A patent/CN105451769A/zh active Pending
- 2014-08-07 RS RS20210305A patent/RS61565B1/sr unknown
- 2014-08-07 US US14/454,138 patent/US9441046B2/en active Active
- 2014-08-07 EP EP14836725.3A patent/EP3033104B1/en active Active
- 2014-08-07 EP EP25191983.3A patent/EP4636400A2/en active Pending
- 2014-08-07 KR KR1020167006576A patent/KR102337599B1/ko active Active
- 2014-08-07 EP EP19158446.5A patent/EP3520811B1/en active Active
- 2014-08-07 LT LTEP14836725.3T patent/LT3033104T/lt unknown
- 2014-08-07 ME MEP-2019-137A patent/ME03403B/me unknown
- 2014-08-07 PL PL14836725T patent/PL3033104T3/pl unknown
- 2014-08-07 CA CA2917603A patent/CA2917603C/en active Active
- 2014-08-07 EP EP20208316.8A patent/EP3875487A1/en not_active Withdrawn
- 2014-08-07 SM SM20210152T patent/SMT202100152T1/it unknown
- 2014-08-07 PL PL19158446T patent/PL3520811T3/pl unknown
- 2014-08-07 BR BR112016002317A patent/BR112016002317A8/pt not_active Application Discontinuation
- 2014-08-07 WO PCT/US2014/050119 patent/WO2015023507A2/en not_active Ceased
- 2014-08-07 HR HRP20190920TT patent/HRP20190920T1/hr unknown
- 2014-08-07 ES ES14836725T patent/ES2733602T3/es active Active
2016
- 2016-01-29 MX MX2021003826A patent/MX2021003826A/es unknown
2019
- 2019-07-03 CY CY20191100700T patent/CY1122033T1/el unknown
2020
- 2020-02-21 AU AU2020201277A patent/AU2020201277A1/en not_active Abandoned
- 2020-04-03 JP JP2020067766A patent/JP2020125304A/ja not_active Withdrawn
2021
- 2021-03-10 HR HRP20210406TT patent/HRP20210406T1/hr unknown
- 2021-03-24 CY CY20211100261T patent/CY1124399T1/el unknown
2022
- 2022-06-07 JP JP2022092222A patent/JP2022120010A/ja active Pending
2024
- 2024-07-05 JP JP2024108997A patent/JP2024129140A/ja active Pending

Also Published As

Publication number	Publication date
HUE043497T2 (hu)	2019-08-28
HUE053627T2 (hu)	2021-07-28
MX2021003826A (es)	2021-05-27
RS58711B1 (sr)	2019-06-28
EP3520811A1 (en)	2019-08-07
WO2015023507A2 (en)	2015-02-19
EP4579236A2 (en)	2025-07-02
RU2016108809A (ru)	2017-09-18
RS61565B1 (sr)	2021-04-29
EP3033104B1 (en)	2019-04-03
EP3875487A1 (en)	2021-09-08
SI3520811T1 (sl)	2021-04-30
SG11201600483QA (en)	2016-02-26
PT3520811T (pt)	2021-03-15
WO2015023507A8 (en)	2015-09-24
MX381102B (es)	2025-03-12
US9441046B2 (en)	2016-09-13
WO2015023507A3 (en)	2015-04-09
JP2020125304A (ja)	2020-08-20
HRP20210406T1 (hr)	2021-04-30
ME03403B (me)	2020-01-20
AU2020201277A1 (en)	2020-03-12
CA2917603A1 (en)	2015-02-19
CA2917603C (en)	2023-05-16
BR112016002317A2 (pt)	2017-12-12
PT3033104T (pt)	2019-06-27
CY1122033T1 (el)	2020-10-14
DK3520811T3 (da)	2021-03-22
LT3033104T (lt)	2019-06-25
EP4636400A2 (en)	2025-10-22
JP2016527325A (ja)	2016-09-08
HRP20190920T1 (hr)	2019-07-12
CN111588849A (zh)	2020-08-28
RU2016108809A3 (pl)	2018-06-18
EP3033104A4 (en)	2017-03-22
JP6746496B2 (ja)	2020-08-26
MX2016001384A (es)	2016-08-03
BR112016002317A8 (pt)	2018-06-12
EP3033104A2 (en)	2016-06-22
SI3033104T1 (sl)	2019-06-28
TR201907907T4 (tr)	2019-06-21
DK3033104T3 (da)	2019-06-17
ES2866426T3 (es)	2021-10-19
AU2014306959A1 (en)	2016-02-04
KR102337599B1 (ko)	2021-12-10
EP3520811B1 (en)	2020-12-30
AU2014306959B2 (en)	2019-11-21
ES2733602T3 (es)	2019-12-02
US20150044203A1 (en)	2015-02-12
RU2703568C2 (ru)	2019-10-21
EP4579236A3 (en)	2025-09-17
LT3520811T (lt)	2021-03-25
KR20160043049A (ko)	2016-04-20
SMT201900311T1 (it)	2019-07-11
CN105451769A (zh)	2016-03-30
JP2022120010A (ja)	2022-08-17
PL3520811T3 (pl)	2021-08-02
JP2024129140A (ja)	2024-09-26
HK1222559A1 (zh)	2017-07-07
HK1225300A1 (en)	2017-09-08
CY1124399T1 (el)	2022-07-22
SMT202100152T1 (it)	2021-05-07

Publication	Publication Date	Title
GB201217018D0 (en)	2012-11-07	Methods
IL240024A0 (en)	2015-09-24	Polystatin in the treatment of Duchenne muscular dystrophy
GB201518891D0 (en)	2015-12-09	Improvements in wheeled suitcases
PL2866854T3 (pl)	2021-01-11	Polimery do zastosowania w sposobach
SG11201600483QA (en)	2016-02-26	Methods for increasing forced expiratory volume in asthmatics using benralizumab
GB201306980D0 (en)	2013-05-29	Methods
GB2507760B (en)	2015-07-08	Methods
PL3008082T3 (pl)	2020-06-01	Sposoby
GB201208874D0 (en)	2012-07-04	Methods
GB201312444D0 (en)	2013-08-28	Methods
GB201308516D0 (en)	2013-06-19	Methods
GB201304234D0 (en)	2013-04-24	Methods
GB201204280D0 (en)	2012-04-25	Methods
PL2887428T3 (pl)	2017-06-30	Akumulator, zwłaszcza akumulator trakcyjny
GB201209689D0 (en)	2012-07-18	Methods
GB201319273D0 (en)	2013-12-18	Improvements in structural members and methods relating thereto
GB201322740D0 (en)	2014-02-05	Methods
GB201303078D0 (en)	2013-04-10	Methods
GB201220686D0 (en)	2013-01-02	Methods
GB201208756D0 (en)	2012-07-04	Methods
GB201322789D0 (en)	2014-02-05	Purge in model
GB201317260D0 (en)	2013-11-13	Improvements in tools for manual use
GB201306564D0 (en)	2013-05-22	Improvements in scooters
GB201304281D0 (en)	2013-04-24	Improvements in bags
GB201302064D0 (en)	2013-03-20	Improvements in pacemakers